default search action

combined dblp search
author search
venue search
publication search

ask others

David Ebuka Arthur

> Home > Persons

Person information

Refine list

refinements active!

zoomed in on ?? of ?? records

view refined list in

export refined list as

showing all ?? records

Journal Articles

see FAQ

What is the meaning of the colors in the publication lists?

2021
[j3]
- view
  authority control:
- export record
  dblp key:
  - journals/netmahib/ArthurASOAAM21
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/journals/netmahib/ArthurASOAAM21
David Ebuka Arthur, Jibrin Noah Akoji, Riadh Sahnoun, Greatman C. Okafor, Karimatu Lami Abdullahi, Sa'ima A. Abdullahi, Charles Mgbemena:
Computational design of novel AKT inhibitors. Netw. Model. Anal. Health Informatics Bioinform. 10(1): 18 (2021)
2018
[j2]
- view
  authority control:
- export record
  dblp key:
  - journals/netmahib/ArthurUMAS18
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/journals/netmahib/ArthurUMAS18
David Ebuka Arthur, Adamu Uzairu, Paul Mamza, Stephen Eyije Abechi, Gideon Adamu Shallangwa:
Structure-based optimization of tyrosine kinase inhibitors: a molecular docking study. Netw. Model. Anal. Health Informatics Bioinform. 7(1): 9 (2018)
[j1]
- view
  authority control:
- export record
  dblp key:
  - journals/netmahib/ArthurUMAS18a
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/journals/netmahib/ArthurUMAS18a
David Ebuka Arthur, Adamu Uzairu, Paul Mamza, Stephen Eyije Abechi, Gideon Shallangwa:
In silico modelling of quantitative structure-activity relationship of multi-target anticancer compounds on k-562 cell line. Netw. Model. Anal. Health Informatics Bioinform. 7(1): 11 (2018)

Coauthor Index

see FAQ

manage site settings

To protect your privacy, all features that rely on external API calls from your browser are turned off by default. You need to opt-in for them to become active. All settings here will be stored as cookies with your web browser. For more information see our F.A.Q.